97126 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F), e.g. Acinetobacter
NEISSERIA GONORRHOEAE DETECTION KIT AND NEISSERIA GONORRHOEAE DETECTION METHOD
#2Vaccines for Neisseria Gonorrhoeae
#3VACCINES FOR NEISSERIA GONORRHOEAE
#4HUMANIZED ANTIBODIES AGAINST NEISSERIA GONORRHOEAE AND METHODS OF USE THEREOF
#5SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#6Peptides and antibodies for the removal of biofilms
#7NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
#8IMMUNOGENIC PROTEIN AGAINST GONOCOCCAL INFECTION
#9ANTI-ACINETOBACTER BAUMANNII POLYCLONAL ANTIBODY (AB-pAb), AND USES THEREOF
#10MULTIVALENT DNA ANTIBODY CONSTRUCTS AND USE THEREOF
#11ANTIBODY MOLECULES AND USES THEREOF
#12IN-VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES
#13SYNTHETIC BINDING AGENTS FOR LIMITING PERMEATION THROUGH MUCUS
#14Peptides and antibodies for the removal of biofilms
#15immunogenic protein and composition and application thereof
#16Recombinant strain AB5075
#17HUMANIZED 2C7 MONOCLONAL ANTIBODY DIRECTED AGAINST A NEISSERIA GONORRHOEAE LIPOOLIGOSACCHARIDE (LOS) EPITOPE, FOR HUMAN USE
#18SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY
#19Polyclonal antibodies specific for serogroup X of N. meningitidis and uses thereof in diagnosis
#20compositions and methods thereof
#21BINDING MOLECULES TARGETING PATHOGENS
#22UspA2 protein constructs and uses thereof
#23Vitro potency assay for protein-based meningococcal vaccines
#24Live attenuated vaccines
#25compositions and methods thereof
#26Immunogenic compositions for the prevention and treatment of meningococcal disease
#27Regimens for immunisation with meningococcal conjugates
#28Non-lipidated variants of ORF2086 antigens
#29Targets of
#30Antibodies for detection of colistin-resistance
#31Vaccines for
#32compositions and methods thereof
#33IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE
#34Gonorrheal MtrE peptides and vaccines
#35SCREENING METHODS FOR IDENTIFYING ANTIBODIES THAT BIND CELL SURFACE EPITOPES
#36Peptides and antibodies for the removal of biofilms
#37Targets of
#38UspA2 protein constructs and uses thereof
#39Antibody binding agents that bind and uses thereof
#40Targets of acinetobacter baumannii
#41Targets of acinetobacter baumannii
#42Targets of
#43compositions and methods thereof
#44Targets of
#45Targets of
#46Targets of
#47Monoclonal antibodies specific for serogroup X of and uses thereof in diagnosis
#48DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#49BINDING MOLECULES TARGETING PATHOGENS
#50Vaccines for
#51ANTIBODIES, VARIABLE DOMAINS & CHAINS TAILORED FOR HUMAN USE
#52Polyclonal antibodies specific for serogroup x of and uses thereof in diagnosis
#53Targets of acinetobacter baumannii
#54Monoclonal antibodies for treatment of microbial infections
#55Immunogenic compositions for the prevention and treatment of meningococcal disease
#56VACCINE
#57Oligosialic acid derivatives, methods of manufacture, and immunological uses
#58UspA2 protein constructs and uses thereof
#59Acinetobacter baumannii antigens and the uses thereof
#60composition and methods thereof
#61Live attenuated vaccines
#62Chimeric Factor H Binding Proteins (fHBP) and Methods of Use
#63DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#64Methods of treating pre-eclampsia or eclampsia
#65Neisseria meningitidis compositions and methods thereof
#66Immunogenic compositions for the prevention and treatment of meningococcal disease
#67In vitro potency assay for protein-based meningococcal vaccines
#68BINDING MOIETIES FOR BIOFILM REMEDIATION
#69Gonorrheal MtrE peptides and vaccines
#70Immunogenic compositions for the prevention and treatment of meningococcal disease
#71BINDING MOLECULES TARGETING PATHOGENS
#72Compositions and Methods for the Removal of Biofilms
#73Targets of
#74COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST DRUG RESISTANT ACINETOBACTER BAUMANNII
#75AXMI205 variant proteins and methods of use
#76TOTAL SYNTHESIS AND IMMUNOLOGICAL EVALUATION OF SACCHARIDE MOIETIES OF THE LIPOPOLYSACCHARIDE FROM NEISSERIA MENINGITIDIS
#77Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
#78compositions and methods thereof
#79porin proteins
#80Vaccine
#81Novel Immunogenic Compositions For The Prevention And Treatment of Meningococcal Disease
#82Immunogenic compositions for the prevention and treatment of meningococcal disease
#83Compositions and methods for immunization against drug resistant
#84Immunogenic compositions for the prevention and treatment of meningococcal disease
#85T-cell stimulating protein B and methods of use
#86De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#87Immunogenic compositions for the prevention and treatment of meningococcal disease
#88Antibiotic comprising an antibody mimetic, its preparation methods and uses thereof
#89Vaccine
#90Chimeric factor H binding proteins (fHbp) and methods of use
#91Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
#92Non-lipidated variants of ORF2086 antigens
#93Outer membrane vesicles and uses thereof
#94NOVEL IMMUNOGENIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF MENINGOCOCCAL DISEASE
#95Ex-vivo passive protection bacteremia assay
#96Mutant bacterial glycoproteins and uses thereof
#97Compositions and methods for the removal of biofilms
#98Methods, compositions and vaccines relating to antibodies
#99Vaccine
#100Immunogenic compositions for the prevention and treatment of meningococcal disease
#101METHODS OF TREATING PRE-ECLAMPSIA OR ECLAMPSIA
#102De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#103BASB006 POLYPEPTIDES FROM NEISSERIA MENINGITIDIS AND IMMUNOGENIC COMPOSITIONS THEREOF
#104MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES
#105Nucleic acids and polypeptides specific of the genus pathogenic strains
#106AFFINITY PURIFIED HUMAN POLYCLONAL ANTIBODIES AND METHODS OF MAKING AND USING THEM
#107BLOCKING INTERACTION BETWEEN PATHOGEN FACTORS AND FACTOR H TO INHIBIT HEMORRHAGIC SYNDROMES
#108Antibodies against neisserial factor H binding protein
#109Outer membrane vesicles and uses thereof
#110outer membrane protein-106 polypeptide, gene sequence and uses thereof
#111Vaccine
#112Vaccine
#113Vaccine
#114Vaccine
#115Regimens for immunisation with meningococcal conjugates
#116ANTIBODIES FOR DETECTING MICROORGANISMS
#117Uses of the FcRn Receptor
#118Nucleic acids and polypeptides specific for pathogenic strains of the genus
#119UspA2 nucleic acid of
#120UspA2 nucleic acid of moraxella catarrhalis
#121Kits for the diagnosis of pre-eclampsia or eclampsia
#122BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis
#123USE OF PENICILLIN-BINDING PROTEINS OR POLYNUCLEOTIDES OR ANTIBODIES THEREOF FOR PREVENTING OR TREATING BACTERIAL INFECTIONS
#124Oligosialic acid derivatives, methods of manufacture, and immunological uses
#125Methods of diagnosing pre-eclampsia or eclampsia
#126Vaccine for periodontitis and methods of use
#127MORAXELLA CATARRHALIS OUTER MEMBRANE PROTEIN-106 POLYPEPTIDE, GENE SEQUENCE AND USES THEREOF
#128Methods of treating pre-eclampsia and eclampsia
#129Sets of digital antibodies directed against short epitopes, and methods using same
#130Regimens for immunisation with meningococcal conjugates
#131outer membrane protein-106 polypeptide, gene sequence and uses thereof
#132Method for producing an in vitro expression library
#133Transferrin-binding proteins from
#134Outer membrane vesicles and uses thereof
#135Pharmaceutical liposomal compositions
#136Immunogenic compositions for the prevention and treatment of meningococcal disease
#137Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
#138Vaccine composition for preventing meningococcal disease
#139Methods for isolating molecular mimetics of unique serogroup B epitopes
#140Methods of diagnosing and treating pre-eclampsia or eclampsia
#141UspA1 and UspA2 antigens of
#142USPA2 nucleic acid of
#143compounds and anti-infection applications thereof
#144Nucleic acids and polypeptides specific for pathogenic strains of the genus
#145Methods of treating pre-eclampsia or eclampsia